Abstract：
Severe opioid withdrawal, risk of patient-initiated discharge, and some inpatients\' use of unregulated substances prompt clinical and ethical questions considered in this commentary on a case. Short-acting opioids can be used to manage inpatients\' pain and opioid use disorder (OUD) withdrawal symptoms. Including evidence-based interventions-such as naloxone kits, substance use equipment, and supervised consumption-in some inpatients\' care plans may make those patients safer and reduce their risk of death. These and other strategies align with clinicians\' ethical duties to minimize harms and maximize benefits for inpatients with OUD.
摘要：
严重的阿片类药物戒断,患者主动出院的风险，和一些住院病人\'使用不受管制的物质提示临床和伦理问题考虑在本评论的一个案例。短效阿片类药物可用于治疗住院患者疼痛和阿片类药物使用障碍（OUD）戒断症状。包括循证干预措施，如纳洛酮试剂盒，物质使用设备，和监督消费-在一些住院患者的护理计划可能会使这些患者更安全，并降低他们的死亡风险。这些和其他策略与临床医生的道德义务相一致，以最大程度地减少OUD住院患者的危害并最大程度地受益。
